Hyperlipidemia Type 3 Latest Advances
Find the Latest Research About Hyperlipidemia Type 3
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 603 publications
APOB to estimated APOB ratio for screening for the APOE2 genotype.
Journal: medRxiv : the preprint server for health sciences
Published: February 26, 2026
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.
Journal: Journal of the American Heart Association
Published: August 23, 2025
Letter to the Editor From Xu and Lu: "Predictors of Cardiovascular Disease in Individuals With Dysbetalipoproteinemia: A Prospective Study in the UK Biobank".
Journal: The Journal of clinical endocrinology and metabolism
Published: June 04, 2025
Dysbetalipoproteinaemia in genetically predisposed Ghanaians.
Journal: Lipids in health and disease
Published: May 26, 2025
Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III.
Journal: Biochemistry and biophysics reports
Published: April 11, 2025
The Challenges of Diagnosing Familial Dysbetalipoproteinemia: A Case Associated With a Rare ApoE Variant.
Journal: Case reports in medicine
Published: February 20, 2025
Correction: Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE.
Journal: Cell communication and signaling : CCS
Published: December 31, 2024
Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia.
Journal: International journal of molecular sciences
Published: October 08, 2024
Evaluating Dyslipidemia and Atherogenic Indices as Predictors of Coronary Artery Disease Risk: A Retrospective Cross-Sectional Study.
Journal: Cureus
Published: October 07, 2024
Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE.
Journal: Cell communication and signaling : CCS
Published: July 23, 2024
Predictors of Cardiovascular Disease in Individuals With Dysbetalipoproteinemia: A Prospective Study in the UK Biobank.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 18, 2024
Last Updated: 04/28/2026